<VariationArchive RecordType="classified" VariationID="6538" VariationName="NM_003722.5(TP63):c.1693_1694del (p.Phe565fs)" VariationType="Deletion" Accession="VCV000006538" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2018-01-08" MostRecentSubmission="2023-04-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21577" VariationID="6538">
      <GeneList>
        <Gene Symbol="TP63" FullName="tumor protein p63" GeneID="8626" HGNC_ID="HGNC:15979" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="189596746" stop="189897276" display_start="189596746" display_stop="189897276" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="189349215" stop="189615067" display_start="189349215" display_stop="189615067" Strand="+" />
          </Location>
          <OMIM>603273</OMIM>
          <Haploinsufficiency last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP63">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP63">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003722.5(TP63):c.1693_1694del (p.Phe565fs)</Name>
      <CanonicalSPDI>NC_000003.12:189890827:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="189890828" stop="189890829" display_start="189890828" display_stop="189890829" variantLength="2" positionVCF="189890827" referenceAlleleVCF="ATT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="189608617" stop="189608618" display_start="189608617" display_stop="189608618" variantLength="2" positionVCF="189608616" referenceAlleleVCF="ATT" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>AF075430.1:c.1576_1577del</Name>
      </OtherNameList>
      <ProteinChange>F386fs</ProteinChange>
      <ProteinChange>F471fs</ProteinChange>
      <ProteinChange>F561fs</ProteinChange>
      <ProteinChange>F563fs</ProteinChange>
      <ProteinChange>F565fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114980.2" sequenceAccession="NM_001114980" sequenceVersion="2" change="c.1411_1412del" MANEPlusClinical="true">
            <Expression>NM_001114980.2:c.1411_1412del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108452.1" sequenceAccession="NP_001108452" sequenceVersion="1" change="p.Phe471fs">
            <Expression>NP_001108452.1:p.Phe471fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329146.2" sequenceAccession="NM_001329146" sequenceVersion="2" change="c.1156_1157del">
            <Expression>NM_001329146.2:c.1156_1157del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316075.1" sequenceAccession="NP_001316075" sequenceVersion="1" change="p.Phe386fs">
            <Expression>NP_001316075.1:p.Phe386fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329148.2" sequenceAccession="NM_001329148" sequenceVersion="2" change="c.1681_1682del">
            <Expression>NM_001329148.2:c.1681_1682del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316077.1" sequenceAccession="NP_001316077" sequenceVersion="1" change="p.Phe561fs">
            <Expression>NP_001316077.1:p.Phe561fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329964.2" sequenceAccession="NM_001329964" sequenceVersion="2" change="c.1687_1688del">
            <Expression>NM_001329964.2:c.1687_1688del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316893.1" sequenceAccession="NP_001316893" sequenceVersion="1" change="p.Phe563fs">
            <Expression>NP_001316893.1:p.Phe563fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003722.5" sequenceAccession="NM_003722" sequenceVersion="5" change="c.1693_1694del" MANESelect="true">
            <Expression>NM_003722.5:c.1693_1694del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003713.3" sequenceAccession="NP_003713" sequenceVersion="3" change="p.Phe565fs">
            <Expression>NP_003713.3:p.Phe565fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114978.2" sequenceAccession="NM_001114978" sequenceVersion="2" change="c.1652+1345_1652+1346del">
            <Expression>NM_001114978.2:c.1652+1345_1652+1346del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329144.2" sequenceAccession="NM_001329144" sequenceVersion="2" change="c.1508-3377_1508-3376del">
            <Expression>NM_001329144.2:c.1508-3377_1508-3376del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114981.2" sequenceAccession="NM_001114981" sequenceVersion="2" change="c.1370+1345_1370+1346del">
            <Expression>NM_001114981.2:c.1370+1345_1370+1346del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329145.2" sequenceAccession="NM_001329145" sequenceVersion="2" change="c.1226-3377_1226-3376del">
            <Expression>NM_001329145.2:c.1226-3377_1226-3376del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329149.2" sequenceAccession="NM_001329149" sequenceVersion="2" change="c.1214-3377_1214-3376del">
            <Expression>NM_001329149.2:c.1214-3377_1214-3376del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329150.2" sequenceAccession="NM_001329150" sequenceVersion="2" change="c.959-3377_959-3376del">
            <Expression>NM_001329150.2:c.959-3377_959-3376del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.189608618_189608619del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.189608618_189608619del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.189890829_189890830del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.189890829_189890830del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007550.3" sequenceAccession="NG_007550" sequenceVersion="3" change="g.299084_299085del">
            <Expression>NG_007550.3:g.299084_299085del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_428" sequenceAccession="LRG_428">
            <Expression>LRG_428:g.299084_299085del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_428t1" sequenceAccession="LRG_428t1">
            <Expression>LRG_428t1:c.1693_1694del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_428p1" sequenceAccession="LRG_428p1" change="p.Phe565fs">
            <Expression>LRG_428p1:p.Phe565fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603273.0012" DB="OMIM" />
        <XRef Type="rs" ID="2108864814" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003722.5(TP63):c.1693_1694del (p.Phe565fs) AND Limb-mammary syndrome" Accession="RCV000006912" Version="5">
        <ClassifiedConditionList TraitSetID="1813">
          <ClassifiedCondition DB="MedGen" ID="C1863753">Limb-mammary syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-01-08" MostRecentSubmission="2023-04-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11462173</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18627043</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9774969</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1813" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2601" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Limb-mammary syndrome</ElementValue>
                <XRef ID="Limb-mammary+syndrome/4243" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011334" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mammary hypoplasia, ectrodactyly, and other hand/foot anomalies</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LMS</ElementValue>
                <XRef Type="MIM" ID="603543" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10051" />
                <XRef ID="10051" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The TP63-related disorders comprise six overlapping phenotypes: Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (which includes Rapp-Hodgkin syndrome). Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome. Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3). Limb-mammary syndrome. Split-hand/foot malformation type 4 (SHFM4). Isolated cleft lip/cleft palate (orofacial cleft 8). Individuals typically have varying combinations of ectodermal dysplasia (hypohidrosis, nail dysplasia, sparse hair, tooth abnormalities), cleft lip/palate, split-hand/foot malformation/syndactyly, lacrimal duct obstruction, hypopigmentation, hypoplastic breasts and/or nipples, and hypospadias. Findings associated with a single phenotype include ankyloblepharon filiforme adnatum (tissue strands that completely or partially fuse the upper and lower eyelids), skin erosions especially on the scalp associated with areas of scarring, and alopecia, trismus, and excessive freckling.</Attribute>
                <XRef ID="NBK43797" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TP63-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20556892</ID>
                <ID Source="BookShelf">NBK43797</ID>
              </Citation>
              <XRef ID="69085" DB="Orphanet" />
              <XRef ID="C1863753" DB="MedGen" />
              <XRef ID="MONDO:0011334" DB="MONDO" />
              <XRef Type="MIM" ID="603543" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27108" SubmissionDate="2018-01-05" DateLastUpdated="2023-04-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603273.0012_LIMB-MAMMARY SYNDROME" title="TP63, 2-BP DEL, 1576TT_LIMB-MAMMARY SYNDROME" />
        <ClinVarAccession Accession="SCV000027108" DateUpdated="2023-04-09" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient (BX) with limb-mammary syndrome (LMS; 603543), who had bilateral split hand/foot malformation, isolated cleft palate, and normal hair, skin, and teeth, but absent nipples, van Bokhoven et al. (2001) identified heterozygosity for a de novo 2-bp deletion (1576_1577delTT) in exon 13 of the TP63 gene, resulting in a frameshift predicted to cause premature termination of the p63-alpha protein within the SAM domain. The numbering of the mutation is according to the sequence reported by Yang et al. (1998). The mutation was not found in the proband's unaffected parents. Guazzarotti et al. (2008) evaluated this patient at age 14 years for primary amenorrhea and found that, although she had normal development of external genitalia and pubic hair and normal morphology of the lower vaginal tract, she had absent uterus and ovaries; hormonal evaluation revealed hypergonadotropic hypogonadism with a very low plasma estrogen level.</Attribute>
              <Citation>
                <ID Source="PubMed">11462173</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9774969</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18627043</ID>
              </Citation>
              <XRef DB="OMIM" ID="603543" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP63" />
          </GeneList>
          <Name>TP63, 2-BP DEL, 1576TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1576TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603273.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIMB-MAMMARY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27108" TraitType="Disease" MappingType="Name" MappingValue="LIMB-MAMMARY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1863753" Name="Limb-mammary syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

